Experimental drug may work against hepatitis C
(HealthDay)—An experimental therapy for hepatitis C—a "silent killer" linked to liver cancer and cirrhosis—has shown promise in tamping down virus levels in early trials.
Mar 27, 2013
1
0
(HealthDay)—An experimental therapy for hepatitis C—a "silent killer" linked to liver cancer and cirrhosis—has shown promise in tamping down virus levels in early trials.
Mar 27, 2013
1
0
Despite showing promising results in a recent phase 2 trial, administration of a novel gene therapy (NV1FGF) to enhance the growth of new blood vessels in people with critical limb ischaemia (whose legs are damaged when blocked ...
May 30, 2011
0
0
The healthy human intestine is colonized with over 100 trillion beneficial, or commensal, bacteria of many different species. In healthy people, these bacteria are limited to the intestinal tissues and have a number of helpful ...
Jun 6, 2012
1
0
The probability that an obese person will develop severe COVID-19 is high regardless of age, sex, ethnicity, and the presence of co-morbidities such as diabetes, high blood pressure, and heart or lung disease, according to ...
Oct 14, 2020
0
74
Celiac disease is more common among Massachusetts children born in the spring or summer, and this higher incidence could be related to the intersection of key seasonal and environmental factors, according to researchers at ...
May 8, 2011
0
0
What are the odds of catching COVID-19 after a night at the movie theater? How about an afternoon at the gym, unmasked? Or an early morning jog in a neighborhood park?
Jan 21, 2022
0
10
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of ...
Apr 26, 2013
0
0
While most cases of type 1 diabetes are classified as autoimmune diseases, a minor proportion of these patients have non-immune-mediated type 1 diabetes, sometimes referred to as type 1 B diabetes. Researchers from Children's ...
Aug 27, 2021
0
255
A scientist at the Gladstone Institutes has discovered a novel way to convert human skin cells into brain cells, advancing medicine and human health by offering new hope for regenerative medicine and personalized drug discovery ...
Jul 28, 2011
0
0
A new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic ...
Feb 8, 2022
1
407